Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Imatinib mesilate

EU orphan designation number: EU/3/05/306
Active ingredient: Imatinib mesilate
Indication: Treatment of mastocytosis
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/09/2005 Orphan designation EMEA/OD/042/05 (2005)3344 of 26/08/2005
10/10/2007 Removal of orphan designation from Community Register